Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion

Endocrine-Related Cancer

Volumn 17, Issue 1, 2010, Pages 99-111

  Liao, Chen Hsin ^a   Yeh, Shih Chi ^a   Huang, Ya Hui ^b   Chen, Ruey Nan ^a   Tsai, Ming Ming ^a   Chen, Wei Jan ^c   Chi, Hsiang Cheng ^a   Tai, Pei Ju ^a   Liao, Chia Jung ^a   Wu, Sheng Ming ^a   Cheng, Wan Li ^a   Pai, Li Mei ^a   Lin, Kwang Huei ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SCLEROPROTEIN; SPONDIN 2 PROTEIN; THYROID HORMONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE LOCATION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR CLONING; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIVER; LIVER NEOPLASMS; MALE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PEPTIDES; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, THYROID HORMONE; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; THYROIDECTOMY; TRIIODOTHYRONINE;

EID: 77449085159     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0050     Document Type: Article

References (53)

1. Barlow C, Meister B, Lardelli M, Lendahl U & Vennstrom B 1994 Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA. EMBO Journal 13 4241-4250.
2. Barrera-Hernandez G, Zhan Q, Wong R & Cheng SY 1998 Thyroid hormone receptor is a negative regulator in p53-mediated signaling pathways. DNA and Cell Biology 17 743-750.
3. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J & Garcia De Herreros A 2000 The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nature Cell Biology 2 84-89.
4. Bhat MK, Yu C, Yap N, Zhan Q, Hayashi Y, Seth P & Cheng S 1997 Tumor suppressor p53 is a negative regulator in thyroid hormone receptor signaling pathways. Journal of Biological Chemistry 272 28989-28993.
5. Blechschmidt K, Sassen S, Schmalfeldt B, Schuster T, Hofler H & Becker KF 2008 The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. British Journal of Cancer 98 489-495.
6. Cano A, Perez-MorenoMA,Rodrigo I,Locascio A, BlancoMJ, del Barrio MG, Portillo F & Nieto MA 2000 The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nature Cell Biology 2 76-83.
7. Chen RN, Huang YH, Lin YC, Yeh CT, Liang Y, Chen SL & Lin KH 2008a Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines. Endocrinology 149 3817-3831.
8. Chen RN, Huang YH, Yeh CT, Liao CH & Lin KH 2008b Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma. Cancer Research 68 1697-1706.
9. Cheng SY 2000 Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Reviews in Endocrine & Metabolic Disorders 1 9-18.
10. Davis FB, Tang HY, Shih A, Keating T, Lansing L, Hercbergs A, Fenstermaker RA, Mousa A, Mousa SA, Davis PJ et al. 2006 Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Research 66 7270-7275.
11. Forrest D, Reh TA & Rusch A 2002 Neurodevelopmental control by thyroid hormone receptors. Current Opinion in Neurobiology 12 49-56.
12. Garcia-Silva S & Aranda A 2004 The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Molecular and Cellular Biology 24 7514-7523.
13. Gervais ML, Henry PC, Saravanan A, Burry TN, Gallie BL, Jewett MA, Hill RP, Evans AJ & Ohh M 2007 Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma. Laboratory Investigation 87 1252-1264.
14. Hall LC, Salazar EP, Kane SR & Liu N 2008 Effects of thyroid hormones on human breast cancer cell proliferation. Journal of Steroid Biochemistry and Molecular Biology 109 57-66.
15. He YW, Li H, Zhang J, Hsu CL, Lin E, Zhang N, Guo J, Forbush KA & Bevan MJ 2004 The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens. Nature Immunology 5 88-97.
16. Hsu SM, Raine L & Fanger H 1981 Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. Journal of Histochemistry and Cytochemistry 29 577-580.
17. Hu L, Lau SH, Tzang CH, Wen JM, Wang W, Xie D, Huang M, Wang Y, Wu MC, Huang JF et al. 2004 Association of vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene 23 298-302.
18. Huang YH, Lee CY, Tai PJ, Yen CC, Liao CY, Chen WJ, Liao CJ, Cheng WL, Chen RN, Wu SM et al. 2006 Indirect regulation of human dehydroepiandrosterone sulfotransferase family 1A member 2 by thyroid hormones. Endocrinology 147 2481-2489.
19. Huang YH, Tsai MM & Lin KH 2008 Thyroid hormone dependent regulation of target genes and their physiological significance. Chang Gung Medical Journal 31 325-334.
20. Humphries MJ, Olden K & Yamada KM 1986 A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 233 467-470.
21. Jia W, Li H & He YW 2005 The extracellular matrix protein mindin serves as an integrin ligand and is critical for inflammatory cell recruitment. Blood 106 3854-3859.
22. Joseph B, Ji M, Liu D, Hou P & Xing M 2007 Lack of mutations in the thyroid hormone receptor (TR) alpha and beta genes but frequent hypermethylation of the TRbeta gene in differentiated thyroid tumors. Journal of Clinical Endocrinology and Metabolism 92 4766-4770.
23. Kato Y, Ying H, Willingham MC & Cheng SY 2004 A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis. Endocrinology 145 4430-4438.
24. Koenig RJ 1998 Thyroid hormone receptor coactivators and corepressors. Thyroid 8 703-713.
25. Laufs S, Schumacher J & Allgayer H 2006 Urokinase-receptor (u-PAR): an essential player in multiple games of cancer: a review on its role in tumor progression, invasion, metastasis, proliferation/dormancy, clinical outcome and minimal residual disease. Cell Cycle 5 1760-1771.
26. Lazar MA 1993 Thyroid hormone receptors: multiple forms, multiple possibilities. Endocrine Reviews 14 184-193.
27. Lin KH, Shieh HY & Hsu HC 2000 Negative regulation of the antimetastatic gene Nm23-H1 by thyroid hormone receptors. Endocrinology 141 2540-2547.
28. Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, Strom S, Demetris AJ, Nalesnik M, Yu YP et al. 2006 Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44 1012-1024.
29. Manda R, Kohno T, Matsuno Y, Takenoshita S, Kuwano H & Yokota J 1999 Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display. Genomics 61 5-14.
30. Olmeda D, Jorda M, Peinado H, Fabra A & Cano A 2007 Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene 26 1862-1874.
31. Parry R, Schneider D, Hudson D, Parkes D, Xuan JA, Newton A, Toy P, Lin R, Harkins R, Alicke B et al. 2005 Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer. Cancer Research 65 8397-8405.
32. Pasqualini R, Bourdoulous S, Koivunen E, Woods VL Jr & Ruoslahti E 1996 A polymeric form of fibronectin has antimetastatic effects against multiple tumor types. Nature Medicine 2 1197-1203.
33. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT et al. 2005 Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transplantation 11 1086-1092.
34. Plateroti M, Kress E, Mori JI & Samarut J 2006 Thyroid hormone receptor alpha1 directly controls transcription of the beta-catenin gene in intestinal epithelial cells. Molecular and Cellular Biology 26 3204-3214.
35. Potts JR & Campbell ID 1994 Fibronectin structure and assembly. Current Opinion in Cell Biology 6 648-655.
36. Rae MT, Gubbay O, Kostogiannou A, Price D, Critchley HO & Hillier SG 2007 Thyroid hormone signaling in human ovarian surface epithelial cells. Journal of Clinical Endocrinology and Metabolism 92 322-327.
37. Rocha AS, Marques R, Bento I, Soares R, Magalhaes J, de Castro IV & Soares P 2007 Thyroid hormone receptor beta mutations in the 'hot-spot region' are rare events in thyroid carcinomas. Journal of Endocrinology 192 83-86.
38. Sambrook J & Russell DW 2001 Molecular cloning: a laboratory manul. In Extraction, Purification, and Analysis of mRNA from Eukaryotic Cells, pp 7.4-7.75. Ed SA Russell., 3 Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
39. Samuels HH, Stanley F & Casanova J 1979 Depletion of L-3,5,3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105 80-85.
40. Shi HY, Zhang W, Liang R, Abraham S, Kittrell FS, Medina D & Zhang M 2001 Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Research 61 6945-6951.
41. Simon I, Liu Y, Krall KL, Urban N, Wolfert RL, Kim NW & McIntosh MW 2007 Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer. Gynecologic Oncology 106 112-118.
42. Singh S, Sadacharan S, Su S, Belldegrun A, Persad S & Singh G 2003 Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer. Cancer Research 63 2306-2311.
43. Sternlicht MD & Werb Z 2001 How matrix metalloproteinases regulate cell behavior. Annual Review of Cell and Development Biology 17 463-516.
44. Tai PJ, Huang YH, Shih CH, Chen RN, Chen CD, Chen WJ, Wang CS & Lin KH 2007 Direct regulation of androgen receptor-associated protein 70 by thyroid hormone and its receptors. Endocrinology 148 3485-3495.
45. Tsui KH, Hsieh WC, Lin MH, Chang PL & Juang HH 2008 Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2. Prostate 68 610-619.
46. Wei J, Xu G, Wu M, Zhang Y, Li Q, Liu P, Zhu T, Song A, Zhao L, Han Z et al. 2008 Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. Anticancer Research 28 327-334.
47. Weiss RE & Ramos HE 2004 Thyroid hormone receptor subtypes and their interaction with steroid receptor coactivators. Vitamins and Hormones 68 185-207.
48. Xiao CZ, Dai YM, Yu HY, Wang JJ & Ni CR 1998 Relationship between expression of CD44v6 and nm23-H1 and tumor invasion and metastasis in hepatocellular carcinoma. World Journal of Gastroenterology 4 412-414.
49. Yap N, Yu CL & Cheng SY 1996 Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53. PNAS 93 4273-4277.
50. Yen PM 2001 Physiological and molecular basis of thyroid hormone action. Physiological Reviews 81 1097-1142.
51. Yin T, Wang C, Liu T, Zhao G, Zha Y & Yang M 2007 Expression of snail in pancreatic cancer promotes metastasis and chemoresistance. Journal of Surgical Research 141 196-203.
52. Ying H, Suzuki H, Zhao L, Willingham MC, Meltzer P & Cheng SY 2003 Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis. Cancer Research 63 5274-5280.
53. Zhao Y, Yan Q, Long X, Chen X & Wang Y 2008 Vimentin affects the mobility and invasiveness of prostate cancer cells. Cell Biochemistry and Function 26 571-577.